论文部分内容阅读
乙型肝炎的治疗至今仍是世界上尚未解决的难题。我国约有10％人口感染乙型肝炎病毒(HBV)。根据我国多数患者是幼龄感染HBV,对病毒不产生有效免疫而处于免疫耐受状态,故不易清除病毒而发展为慢性肝炎或长期携带者。为研究消除免疫耐受途径,需要建立类似幼龄感染的免疫耐受动物模型。由于鸭乙型肝炎病毒
The treatment of hepatitis B is still the unsolved problem in the world. About 10% of China’s population is infected with hepatitis B virus (HBV). According to the majority of our patients are young infected with HBV, the virus does not produce effective immunity and immune tolerance in the state, it is not easy to remove the virus and the development of chronic hepatitis or long-term carriers. In order to study ways to eliminate immune tolerance, we need to establish animal models of immune tolerance similar to young ones. Due to duck hepatitis B virus